Combination of Fruquintinib with Venetoclax for the Treatment of Colorectal Cancer
ONCOLOGY RESEARCH（2025）
Key words
Colorectal cancer (CRC),B-cell lymphoma protein 2 (BCL2),Venetoclax,Vascular endothelial growth factor receptor (VEGFR),Fruquintinib,Anti-angiogenesis,Immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined